Skip to main content

Steroid Recalled

March 15, 2021

Jubilant Cadista Pharmaceuticals Inc. is recalling 635,400 cartons of methylprednisolone blister packs after a customer reported illegible dosing instructions on the blister cards, according to the March 10, 2021, US Food and Drug Administration (FDA) Enforcement Report. 

The recall affects 21-count blister packs of methylprednisolone tablets, 4 mg, Jubilant Cadista Pharmaceuticals, Salisbury, MD (NDC 59746-001-03), from lots 20K0043P (Exp. 8/22), 20K0044P (Exp. 8/22), 20K0042P (Exp. 8/22), 20L0026P (Exp. 9/22), 20L0027P (Exp. 9/22), 20L0028P (Exp. 9/22), 20L0029P (Exp. 9/22), and 20L0030P (Exp. 9/22). The product was distributed throughout the United States, including Puerto Rico. 

Jubilant Cadista Pharmaceuticals voluntarily initiated the recall February 19, 2021. On March 4, 2021, the FDA designated the recall Class III, suggesting use of the recalled drugs is not likely to cause harm. 

Methylprednisolone is a prescription steroid used to treat a variety of medical problems, including arthritis, blood disorders, and severe allergic reactions. 

Jolynn Tumolo

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
11 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top